NGX Bio is a biotechnology startup, founded in 2014 and headquartered in the United States. The company's platform simplifies next-generation sequencing projects by connecting customers to world-class genomic resources, enabling researchers to complete sequencing projects in a single transaction. NGX Bio's approach streamlines projects, making them cost-effective by sourcing the best providers with available capacity.
The company received a $3.00M Venture Round investment on 15 August 2017, with participation from Third Kind Venture Capital, 180 Degrees Capital, Band of Angels, and the Berkeley Angel Network. This investment signifies the confidence of prominent venture capital firms in NGX Bio's potential to revolutionize the biotechnology industry.